European packaging compliance review under the PPWR, covering regulatory requirements, packaging assessment and preparation for the Regulation’s general application from 12 August 2026.

The FDA has published the OMUFA fees applicable during fiscal year 2027, including facility fees for OTC drug manufacturers, CMO fees, OMOR rates and a new two-installment payment schedule.

A federal court has temporarily blocked enforcement of California SB 343. Discover what the decision means for recyclability claims and packaged products.

The Australian Industrial Chemicals Introduction Scheme has published its final evaluation of retinal, also known as retinaldehyde, resulting in new restrictions on its import into Australia. From 26 June 2026, retinal can no longer be imported into Australia either as a cosmetic raw material or as an ingredient in finished cosmetic products, unless the importer holds the appropriate authorisation following an AICIS assessment. The decision applies specifically to retinal and

California’s Department of Toxic Substances Control has finalised a new regulation covering nail products that contain Triphenyl Phosphate (TPhP) at concentrations above 250 parts per million. The regulation will take effect on 1 October 2026 and will classify affected nail products as Priority Products under California’s Safer Consumer Products framework. The measure is intended to address potential health risks associated with exposure to TPhP, particularly for nail salon p